Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
A multi-center, randomized, double-blind, placebo-controlled, therapeutic exploratory, phase II clinical trial for the efficacy investigation and safety evaluation of DWP708 for treating epidermal growth factor receptor inhibitor related skin toxicities
- Authors
- Kim, H. R.; Kang, J. H.; Kim, S. T.; Kim, C. K.; Hwang, I. G.; Ahn, H. K.; Shin, S. H.; Ji, J. H.; Oh, S. B.; Kang, S. Y.; Yi, S. Y.; Maeng, C. H.; Lee, K. H.; Shim, H.; Lee, S-c.; Oh, S. Y.
- Issue Date
- Sep-2025
- Publisher
- Oxford University Press
- Citation
- Annals of Oncology, v.36
- Indexed
- SCIE
SCOPUS
- Journal Title
- Annals of Oncology
- Volume
- 36
- ISSN
- 0923-7534
1569-8041
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > Department of Medicine > Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.